Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-01

Clinical Trial Update: Blood Glucose Self Monitoring and HbA1c Effects on Glucose Control [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial examined the effects of blood glucose self-monitoring and HbA1c on glucose control in individuals with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Deutsche Diabetes Gesellschaft | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED